Clinical Trial Update: A Study to Explore the Effect of Sepranolone in Tourette Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for Sepranolone in Tourette Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome
• Tourette Syndrome in Adolescence

Drugs mentioned

• Sepranolone (UC1010)

Snippet

Sponsor: Asarina Pharma | Conditions: Tourette Syndrome, Tourette Syndrome in Adolescence | Phase 2 | Status: COMPLETED